Questioning the Safety and Benefits of Evolocumab – Authors' Reply
The Lancet Diabetes and Endocrinology - Netherlands
doi 10.1016/s2213-8587(17)30403-5
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2018
Authors
Publisher
Elsevier BV